Laserscope (NASDAQ LSCP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Laserscope (NASDAQ LSCP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: timmask who wrote (82)	8/28/1997 8:47:00 PM
From: Daniel Kahn	of 314

Photofrin has already been approved for lung cancer in France, Germany, and I believe in Japan as well. It has also been approved in the US for esophageal cancer. Can't say for sure, but it appears as if approval here is quite probable for lung as well. Also FYI, there was an article in Investors Business Daily about photofrin several months ago that basically said photofrin and lasers would become as common a cancer treatment over the next 10 years as radiation and chemo are today. None of these treatments are cures, but the side effects from photofrin and lasers are much less debilitating than the other options. Hope this helps answer your question and also hope it helps out our investment in LSCP!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next